CClinicalTrials.gg
RecruitingNCT05555394BATBFUpdated May 8, 2025

Body Awareness Therapy and Biomarkers in Fibromyalgia

An interventional study of Basic Body Awareness Therapy and Stretching Exercise in Fibromyalgia, sponsored by Universitat de Lleida. Recruiting at 2 sites in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-05-08.

Sponsored by Universitat de Lleida · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

A randomized trial of Basic Body Awareness Therapy (BBAT) is applied in fibromyalgia patients as compared with a control intervention consisting of stretching. Sessions of BBAT lasted 90 min each and took place twice a week form 12 weeks. The primary end point is a change in the biomarkers and neurotransmitters and the Fibromyalgia Impact Questionnaire and the secondary end points include Visual Analog Scale, State Trait Anxiety inventory, Beck Depression Inventory. All assessments will be repeated at post treatment, 12 and 24 weeks and 1 year follow-up.

Read the detailed description

This work is a clinical trial of randomized and controlled groups. The hypothesis of study is that BBAT applied in patients with fibromyalgia improves, more than stretching exercises, the pain, normalization biomarkers, improve in psychological state and quality life.

The study population will be selected followed the inclusion criteria of fibromyalgia, and will be selected in Consorci Sociosanitari of Anoia, the patients will be divided in 2 groups, control and treatment group. The groups will be examined at the begin, at 2 weeks, at the end of treatment and 3, 6 and 12 months follow-up.

The dependence measurements will be biomarkers serotonin, dopamine and cortisol, also Visual Analog Scale, State Trait Anxiety Inventory (STAI A/R), Beck Depression Inventory (BDI-II) and Fibromyalgia Impact Questionnaire (FIQ). The independence measurements will be demographic items: sex, age, country, level of studies, social status...

02

Conditions studied

  • Fibromyalgia

Keywords

  • Body awareness therapy
  • physical therapy
  • serotonin
  • cortisol
03

In context

Fibromyalgia

1,335 studies on the registry are indexed under Fibromyalgia; 265 are open to participants now.

This study's planned enrollment of 110 is above the median of 60 across 1,034 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Universitat de Lleida is the lead sponsor of 33 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • whose diagnosed of fibromyalgia almost 6 months before
  • whose could be in different position such as lying, sitting, and stand-up

Exclusion criteria

Exclusion Criteria:

  • whose are diagnosed of disease that it worse the pain
  • pregnancy
  • whose are diagnosed of other disease such as rheumatology, neurology, cardiac problems o another internal medical condition,malignant disease or acute infections
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
110 participants (estimated)

Study arms

  • Experimental
    Basic Body Awareness Therapy

    the Basic Body Awareness Therapy is usual therapy of physiotherapy in mental health in nord europe. BBAT is based in twelve movements and massage that improve the movements quality of patient, also improves other movement qualities like biomechanical, physiologic, socio-cultural and existential

    Other: Basic Body Awareness Therapy

  • Active comparator
    Stretching group

    Stretching exercise will be developed in control group in order to blind the intervention of interest. It will consist in analytic stretching of trunk, upper and lower limb. It will last around 45 min twice a week during 12 weeks.

    Other: Stretching Exercise

Interventions

  • OtherBasic Body Awareness Therapy

    The intervention will be twice a week during 12 weeks. It lasts 90 min of movements of daily life, massage and self-reflections.

    Also known as: BBAT

  • OtherStretching Exercise

    It consists in stretching movements of whole body

06

What researchers measure

Primary outcomes

  1. Serotonin

    Neurotransmitter neurologic

    Time frame: through study completion, an average of 1 year

  2. cortisol

    acute hormone relating stress

    Time frame: during the procedure

Secondary outcomes

  1. Visual Analog Scale (VAS)

    Assess of subjective pain of patient. It consists in a number between 0 to 10

    Time frame: through study completion, an average of 1 year

  2. Fibromyalgia Impact Questionnaire (FIQ)

    Questionnaire about the impact of symptoms of Fibromyalgia in daily life. It measures 21 items with a total score between 0 to 100. The main average is 50.

    Time frame: through study completion, an average of 1 year

  3. Beck Depression Inventory- II (BDI-II)

    Questionnaire for assess the depression of patient. It consists in 21 items with scale ranking from 0-3 with a total score from 0-63. A score between 10-18 corresponds to mild to moderate depression, further than 30 corresponds to severe depression

    Time frame: through study completion, an average of 1 year

  4. State Trait Anxiety Inventory (STAI)

    Questionnaire for assess the anxiety of patient. It consists in 20 questions that score range from 20 to 80. The higher scores correlating with greater anxiety. The questionnaire provide information about state (how a person is feeling at the time) and trait (how people feel across typical situations that everyone experiences on a daily basis)

    Time frame: through study completion, an average of 1 year

07

Study locations

2 of 2 sites recruiting
  • Consorci Sanitari de l'Anoia
    Igualada, Barcelona 08700, Spain
    • Aurora Garriga, Dr · Contact · agarriga@csa.cat · +34 8075800
    • Cristina Bravo, Pt · Sub investigator
    Recruiting
  • Cristina Bravo Navarro
    Igualada, Barcelona 08700, Spain
    Recruiting
08

References and documents

Publications

  • Atasever M, Namli Kalem M, Sonmez C, Seval MM, Yuce T, Sahin Aker S, Koc A, Genc H. Lower serotonin level and higher rate of fibromyalgia syndrome with advancing pregnancy. J Matern Fetal Neonatal Med. 2017 Sep;30(18):2204-2211. doi: 10.1080/14767058.2016.1243096. Epub 2016 Nov 29. PubMed 27696917 ↗
  • Busch AJ, Webber SC, Brachaniec M, Bidonde J, Bello-Haas VD, Danyliw AD, Overend TJ, Richards RS, Sawant A, Schachter CL. Exercise therapy for fibromyalgia. Curr Pain Headache Rep. 2011 Oct;15(5):358-67. doi: 10.1007/s11916-011-0214-2. PubMed 21725900 ↗
  • Bravo C, Skjaerven LH, Espart A, Guitard Sein-Echaluce L, Catalan-Matamoros D. Basic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial. Physiother Theory Pract. 2019 Oct;35(10):919-929. doi: 10.1080/09593985.2018.1467520. Epub 2018 May 3. PubMed 29723080 ↗
  • Bravo C, Skjaerven LH, Guitard Sein-Echaluce L, Catalan-Matamoros D. Effectiveness of movement and body awareness therapies in patients with fibromyalgia: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2019 Oct;55(5):646-657. doi: 10.23736/S1973-9087.19.05291-2. Epub 2019 May 15. PubMed 31106558 ↗
  • Coppieters I, Cagnie B, Nijs J, van Oosterwijck J, Danneels L, De Pauw R, Meeus M. Effects of Stress and Relaxation on Central Pain Modulation in Chronic Whiplash and Fibromyalgia Patients Compared to Healthy Controls. Pain Physician. 2016 Mar;19(3):119-30. PubMed 27008285 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05555394
Lead sponsor
Universitat de Lleida
Collaborators
Consorci Sanitari de l'Anoia
Responsible party
Cristina Bravo (Postdoctoral Researcher, Universitat de Lleida) — Principal investigator
First posted
Sep 26, 2022
Start date
May 8, 2024
Primary completion
May 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
May 8, 2025

Study contacts

Cristina Bravo, PhD
Contact
cristina.bravo@udl.cat
+34 656312125

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion